Exp Clin Endocrinol Diabetes 2004; 112(4): 157-170
DOI: 10.1055/s-2004-817927

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Diabetes and Cardiovascular Risk Evaluation and Management in Primary Care: Progress and Unresolved Issues

Rationale for a Nationwide Primary Care Project in GermanyS. Böhler1 , 2 , H. Glaesmer3 , D. Pittrow4 , H. Lehnert5 , G. K. Stalla6 , A. M. Zeiher7 , W. März8 , S. Silber9 , M. Wehling10 , G. Ruf11 , A. Reinecke3 , H.-U. Wittchen3 , 12
  • 1Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, Dresden, Germany
  • 2Internat. Med. Research, Pfizer GmbH, Freiburg, Germany
  • 3Institute of Clinical Psychology and Psychotherapy, Tech. University of Dresden, Dresden, Germany
  • 4Institute of Clinical Pharmacology, Research Fed. Public Health Sachsen, Tech. University of Dresden, Dresden, Germany
  • 5Department of Endocrinology and Metabolic Disorders, Otto-v.-Guericke-University Magdeburg, Magdeburg, Germany
  • 6Department of Endocrinology, Max Planck Institute of Psychiatry, Munich, Germany
  • 7Department of Cardiology/Nephrology, Johann-Wolfgang-Goethe-University Frankfurt, Frankfurt, Germany
  • 8Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
  • 9Society of German Cardiologists in Private Practice, Munich, Germany
  • 10Institute of Clinical Pharmacology Mannheim, University of Heidelberg, Mannheim, Germany
  • 11Clinical Research, Pfizer GmbH, Karlsruhe, Germany
  • 12Department of Clinical Psychology and Epidemiology, Max Planck Institute of Psychiatry, Munich, Germany
Further Information

Publication History

Received: June 23, 2003 First decision: September 10, 2003

Accepted: October 30, 2003

Publication Date:
04 May 2004 (online)


This review highlights established and more recently recognized risk factors for coronary heart disease (CHD) relevant for patients seen in primary care, emphasizing the key role of diabetes mellitus type 2. Recent trends in risk factor research as well as current methods of risk stratification, and new systemic markers are discussed. Beyond the need for more forceful public health strategies to improve early recognition and intervention, the necessity of an integrated comprehensive investigation of the overall characteristics of cardiovascular disease, especially in primary care patients as a prerequisite for future concerted actions is pointed out. Based on this, a large-scale epidemiological investigation focusing on CHD and diabetes in the primary care sector is suggested.


H. Glaesmer

Institute of Clinical Pharmacology Mannheim
University of Heidelberg

Theodor-Kutzer-Ufer 1 - 3

68167 Mannheim


Phone: + 4935146336985

Fax: + 49 3 51 46 33 69 84

Email: glaesmer@psychologie.tu-dresden.de